Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '584 claims 1 through 28 remain unchanged

Why is it that claim 29 has been isolated from the preceding 28 claims?

The patent consists of 29 interdependent claims, NOT 29 individual claims. To single out any claim and suggest that it stands or falls without reference to all of the other claims makes a mockery of common sense.

Yes, claim 29 was refined to obviate prior art allegations, but it now has to be read in conjunction with the preceding 28 claims.

I trust that this simplification clarifies the situation for those who might wish to continue taking claim 29 as totally unrelated to all the others. Using the fishing nets analogy, it's like taking a knot and saying, this won't catch any fish.





Be well

Share
New Message
Please login to post a reply